Vanguard Group Inc Plus Therapeutics, Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.3 - $0.48 $115 - $184	385 Added 0.04%	1,092,953 $349,000
Q3 2022 Nov 14, 2022	BUY	$0.48 - $1.0 $113,905 - $237,304	237,304 Added 27.75%	1,092,568 $486,000
Q1 2022 May 13, 2022	BUY	$0.87 - $1.32 $123,902 - $187,990	142,417 Added 19.98%	855,264 $855,000
Q2 2021 Aug 13, 2021	BUY	$2.0 - $2.89 $1.43 Million - $2.06 Million	712,847 New	712,847 $1.83 Million

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $50.4M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.